Proposed Accounting Changes Dampen Biotech Funding Sources
This article was originally published in Start Up
Executive Summary
Unfortunately, given the dismal state of the financial markets for biotech, proposed changes in accounting rules will make it significantly more difficult to raise money through spin-offs and corporate partnering transactions as well as make it more difficult to acquire another biotechnology company.